METHODS	The experiment arm ( RT/BUdR plus PCV ) was to be compared to the control arm ( RT plus PCV ) using an alpha = 0.05 , one-tailed , with a power of 85 % for detecting an increase in median survival from 160 to 240 weeks , assuming a 3-year follow-up after completion of enrollment .\